Abstract |
Resveratrol is known to improve endothelial function in animals, but little is known about its effect on human subjects. Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors underlying endothelial dysfunction. We hypothesized that the modified resveratrol, Longevinex, improves endothelial function in patients with MetS. Thirty-four patients who had been treated for MetS and lifestyle-related disease were randomly assigned to group A, in which Longevinex was administered for 3 months and then discontinued for 3 months, whereas in the time-matched group B, Longevinex was administered between 3 and 6 months. These 2 groups of patients received similar drugs at baseline for diabetes mellitus, dyslipidemia, or hypertension. Flow-mediated dilatation significantly increased during the administration of Longevinex but decreased to baseline 3 months after the discontinuation of Longevinex in the group A patients. Conversely, in the group B patients, flow-mediated dilatation remained unchanged for the first 3 months without Longevinex but was significantly increased 3 months after the treatment with Longevinex. Longevinex did not significantly affect blood pressure, insulin resistance, the lipid profile or inflammatory markers during 6-month follow-up. These results demonstrate that Longevinex specifically improves endothelial function in subjects with MetS who were receiving standard therapy for lifestyle-related disease.
|
Authors | Keisuke Fujitaka, Hajime Otani, Fusakazu Jo, Hiromi Jo, Emiko Nomura, Masayoshi Iwasaki, Mitsushige Nishikawa, Toshiji Iwasaka, Dipak K Das |
Journal | Nutrition research (New York, N.Y.)
(Nutr Res)
Vol. 31
Issue 11
Pg. 842-7
(Nov 2011)
ISSN: 1879-0739 [Electronic] United States |
PMID | 22118755
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Stilbenes
- Vasodilator Agents
- Resveratrol
|
Topics |
- Aged
- Diabetes Mellitus
(drug therapy)
- Drug Compounding
- Endothelium, Vascular
(physiopathology)
- Female
- Humans
- Hyperlipidemias
(complications, drug therapy)
- Hypertension
(complications, drug therapy)
- Insulin Resistance
- Life Style
- Male
- Metabolic Syndrome
(complications, drug therapy, physiopathology)
- Middle Aged
- Resveratrol
- Stilbenes
(administration & dosage)
- Vasodilation
- Vasodilator Agents
(administration & dosage)
|